Where Does FDA Go From Here? – FDA Watch
Wayne chats with Paul Kim, Principal of Kendall Square Policy Strategies LLC, and Stuart Pape, Senior Partner and Food and Drug Chair at Polsinelli. Together, they discuss the resignation of Dr. Marty Makary as FDA Commissioner, the installment of former Deputy Commissioner of Human Foods Kyle Diamantas as Acting Head of the agency, qualifications for FDA Commissioner, potential timing of a new official Commissioner, and much more.
This episode and all bonus episodes do not include the usual Headlines and Resources Links segments.
About Our Guests
Paul Kim
Paul T. Kim, JD, MPP, is principal of Kendall Square Policy Strategies LLC, providing advice on FDA, life science, and public health policy to Fortune 500 companies, national patient advocates, life science trade associations, and emerging companies in the US, Europe and Korea.
Paul was head of the FDA and federal government strategies practices at a leading law firm for 20 years, following his work as counsel to the late Senator Edward Kennedy, Congressman Henry Waxman, and the late Senator David Pryor. Paul also worked for the FDA, the American Foundation for AIDS Research, and a global biopharmaceutical.
Stuart Pape
Stuart Pape is a Senior Partner and Food and Drug Chair at Polsinelli. He consults clients on regulations imposed by the U.S. Food and Drug Administration (FDA), U.S. Department of Agriculture (USDA), and similar health and safety regulatory bodies worldwide.
Stuart regularly appears before the FDA, USDA, Consumer Product Safety Commission, U.S. Customs and Border Protection, Federal Trade Commission, numerous other federal and state regulatory bodies, and the Congress of the United States. Stuart serves clients across the U.S. and around the world in many capacities. Previously, he served in various positions in the Office of the Chief of Counsel at the FDA, including as Associate Chief Counsel for food. He also served as executive assistant to FDA Commissioner Donald Kennedy.
FDA Watch Podcast 